September 27, 2019 / 9:18 PM / a month ago

Sanofi wins first bellwether trial in Taxotere litigation

A jury in Louisiana federal court has found that Sanofi’s breast cancer chemotherapy drug Taxotere did not cause a woman to develop permanent hair loss, in the first of thousands of lawsuits over the drug to go to trial.

The verdict was handed down late Thursday following a trial before U.S. District Judge Jane Triche Milazzo in New Orleans. The case, filed in December 2016 by Louisiana resident Barbara Earnest, had been designated as a bellwether in a multidistrict litigation consolidated before Milazzo.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below